Forbes -
5 Apr 2021 16:00

Haemonetics stock, best known for its blood and plasma supplies and services, has fallen by 3.5% in the last week, while it is down 7% over the last ten days. HAE stock has been on a decline since it reported its fiscal Q3 2021 results in early February, 2021. It has corrected over 20% from levels..
Share this Article